title: Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
abstract: The clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of chronic kidney disease mineral and bone disorders (CKD-BMD) in adults, of the Latin American Society of Nephrology and Hypertension (SLANH) comprise a set of recommendations developed to support the doctor in the management of these abnormalities in adult patients with stages 3-5 kidney disease. This excludes changes associated with renal transplantation. The topics covered in the guidelines are divided into four chapters: 1) Evaluation of biochemical changes, 2) Evaluation of bone changes, 3) Evaluation of vascular calcifications, and 4) Treatment of CKD-MBD. The guidelines are based on the recommendations proposed and published by the Kidney Disease: Improving Global Outcomes (KDIGO) for the prevention, diagnosis, evaluation and treatment of CKD-MBD (KDIGO Clinical practice guidelines for the diagnosis, evaluation, prevention and treatment of Chronic Kidney Disease Mineral and Bone Disorder [CKD-MBD]), adapted to the conditions of patients, institutions and resources available in Latin America, with the support of KDIGO. In some cases, the guidelines correspond to management recommendations directly defined by the working group for their implementation in our region, based on the evidence available in the literature. Each chapter contains guidelines and their rationale, supported by numerous updated references. Unfortunately, there are few controlled studies with statistically sufficient weight in Latin America to support specific recommendations for the region, and as such, most of the references used correspond to studies carried out in other regions. This highlights the need to plan research studies designed to establish the current status of mineral and bone metabolism disorders in Latin America as well as defining the best treatment options for our population.
authors: Hospital Universitario de Caracas, Caracas, Venezuela.ebellorinfont@gmail.com
authors: Ezequiel
authors: E
authors: Bellorin-Font
authors: Pablo
authors: P
authors: Ambrosoni
authors: Raúl G
authors: RG
authors: Carlini
authors: Aluizio B
authors: AB
authors: Carvalho
authors: Ricardo
authors: R
authors: Correa-Rotter
authors: Alfonso
authors: A
authors: Cueto-Manzano
authors: Aquiles
authors: A
authors: Jara
authors: Vanda
authors: V
authors: Jorgetti
authors: Armando L
authors: AL
authors: Negri
authors: Armando
authors: A
authors: Negri
authors: Inés
authors: I
authors: Olaizola
authors: Isidro
authors: I
authors: Salusky
authors: Eduardo
authors: E
authors: Slatopolsky
authors: José R
authors: JR
authors: Weisinger
mesh_terms: D001851:Bone Diseases, Metabolic / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D008659:Metabolic Diseases / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D008903:Minerals / Q000378:metabolism*; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D061205:Vascular Calcification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
chemical_list: D008903:Minerals